相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma
Marc de Perrot et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
Kimberley M. Heinhuis et al.
JAMA ONCOLOGY (2020)
Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
Thomas A. Waldmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Biological role of GITR/GITRL in attributes and immune responses of macrophage
Zhuo Fu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Arnaud Scherpereel et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
IL-15 in the Combination Immunotherapy of Cancer
Thomas A. Waldmann et al.
FRONTIERS IN IMMUNOLOGY (2020)
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma
Brendan Curti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
Breanna M. Allen et al.
NATURE MEDICINE (2020)
Radiotherapy in the era of immunotherapy: teaching an old dog new tricks
B. C. John Cho et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Cytokines that target immune killer cells against tumors
Jian Qiao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses
Karsten A. Pilones et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Irina Larionova et al.
FRONTIERS IN ONCOLOGY (2020)
Rational design of anti-GITR-based combination immunotherapy
Roberta Zappasodi et al.
NATURE MEDICINE (2019)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Michele Carbone et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation
Jianzhou Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
Arnaud Scherpereel et al.
LANCET ONCOLOGY (2019)
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Rizwan Romee et al.
BLOOD (2018)
Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
Licun Wu et al.
BMC CANCER (2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas et al.
CANCER CELL (2018)
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M. Wrangle et al.
LANCET ONCOLOGY (2018)
GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
Simran S. Sabharwal et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
Jonathan E. Schoenhals et al.
FRONTIERS IN IMMUNOLOGY (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors
Kim Margolin et al.
CLINICAL CANCER RESEARCH (2018)
Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers
Claire Vanpouille-Box et al.
CLINICAL CANCER RESEARCH (2018)
The potential and promise of IL-15 in immuno-oncogenic therapies
Tanya O. Robinson et al.
IMMUNOLOGY LETTERS (2017)
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis
David B. Nelson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Radiotherapy for the treatment of malignant pleural mesothelioma
Marc de Perrot et al.
LANCET ONCOLOGY (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen
Gilda G. Hillman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model
Luis De La Maza et al.
CLINICAL CANCER RESEARCH (2017)
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade
Simon J. Dovedi et al.
CLINICAL CANCER RESEARCH (2017)
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters
Alison M. McDonnell et al.
BMC CANCER (2017)
In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments
Zachary S. Morris et al.
CANCER RESEARCH (2016)
GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
Xiang Xiao et al.
NATURE COMMUNICATIONS (2015)
Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model
Licun Wu et al.
ONCOTARGET (2015)
Mesothelioma Tumor Cells Modulate Dendritic Cell Lipid Content, Phenotype and Function
Joanne K. Gardner et al.
PLOS ONE (2015)
Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma
Licun Wu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy
B. C. John Cho et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy
Sebastien Anguille et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2: Tumor and Immunological Responses
Steven K. Seung et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Interleukin-15 biology and its therapeutic implications in cancer
Jason C. Steel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
Kai-Ping Han et al.
CYTOKINE (2011)
Characterization of image quality and image-guidance performance of a preclinical microirradiator
R. Clarkson et al.
MEDICAL PHYSICS (2011)
Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
David Coe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Synergistic Antitumor Effects of Regulatory T Cell Blockade Combined with Pemetrexed in Murine Malignant Mesothelioma
Masaki Anraku et al.
JOURNAL OF IMMUNOLOGY (2010)
Distinct Roles for IL-2 and IL-15 in the Differentiation and Survival of CD8+ Effector and Memory T Cells
Diana M. Mitchell et al.
JOURNAL OF IMMUNOLOGY (2010)
Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation
Adam D. Cohen et al.
PLOS ONE (2010)
Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
Meili Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
Sergio A. Quezada et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Soluble interleukin-15 receptor α (IL-15Rα)-sushi as a selective and potent agonist of IL-15 action through IL-15Rβ/γ -: Hyperagonist IL-15•IL-15Rα fusion proteins
E Mortier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature:: A novel mechanism for IL-21
C Jackaman et al.
JOURNAL OF IMMUNOLOGY (2003)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
CD4+CD25+ immunoregulatory T cells:: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor
RS McHugh et al.
IMMUNITY (2002)
分享论文
